Hepatitis C virus antigens — Drug Target

All drugs that target Hepatitis C virus antigens — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Viral vector vaccine

Marketed (1)

• Hep-V Vax · University of Oxford · Viral vector vaccine · Immunology / Infectious Disease
  Hep-V Vax is a viral vector-based vaccine that delivers hepatitis C viral antigens to stimulate immune responses against hepatitis C infection.